Top Abstract Purchase Related
Home
>
Node
>
Subnode

New treatments of ANCA-associated vasculitis

Kallenberg, C.G.; Tervaert, J.W.

Sarcoidosis Vasculitis and Diffuse Lung Diseases Official Journal of Wasog 17(2): 125-129

2000

ISSN/ISBN: 1124-0490
PMID: 10957760
Document Number: 519016
The ANCA-associated systemic vasculides are, in many cases, life-threatening conditions. Combined treatment with corticosteroids and cyclophosphamide has improved their prognosis considerably. Five year survival does, however, still not exceed 75%, due to the occurrence of treatment resistant cases and the severe adverse effects of this treatment regimen. In this review new treatment modalities are discussed. In cases resistant to conventional therapy high dose intravenous immunoglobulin and T-cell directed biologicals, that is anti-thymocyte globulin (ATG) and humanised monoclonal antibodies to CD4 and CDw52, may be effective. Also, TNF-directed treatment is being used. Less severe cases may benefit from methotrexate treatment instead of cyclophosphamide. For maintenance of remission azathioprine has been proven to be as effective as cyclophosphamide so preventing the toxicity of long-term cyclophosphamide treatment. Relapses may also be prevented by treatment based on changes in ANCA-titers or by elimination of Staphylococcus aureus carriage which is associated with relapsing disease in Wegener's Granulomatosis. Several of those new treatment modalities are now being tested in controlled studies by the European Vasculitis Study Group (EUVAS).

Document emailed within 1 workday
Secure & encrypted payments

Helmchen, U.; Kneissler, U.; Prall, F. 1996: ANCA-associated forms of vasculitis Verhandlungen der Deutschen Gesellschaft für Pathologie 80: 38-45
Arimura, Y.; Kawashima, S.; Yoshihara, K. 2009: ANCA associated vasculitis and PRGN Nihon Jinzo Gakkai Shi 51(2): 88-93
Day, C.J.; Hewins, P.; Savage, C.O. 2003: New developments in the pathogenesis of ANCA-associated vasculitis Clinical and Experimental Rheumatology 21(6 Suppl 32: S35-S48
Keller, K.K.; Nielsen, B.D.; Hauge, E.M.; Hansen, I.T.øn. 2015: Diagnostics and treatment of ANCA-associated vasculitis Ugeskrift for Laeger 177(41): V12140721
Coaccioli, S.; Candelori, A.; Puxeddu, A. 2009: Modern therapeutic approach to ANCA-associated vasculitis La Clinica Terapeutica 160(1): 69-82
Pandey, S.; Kushwaha, R.S.; Mehndiratta, P.; Mehndiratta, M.M. 2008: Carbimazole induced ANCA positive vasculitis Journal of the Association of Physicians of India 56: 801-803
Oliveira, D.B.; Lockwood, C.M. 1992: The autoimmune basis of ANCA positive systemic vasculitis Annales de Medecine Interne 143(6): 396-398
Falk, R.J.; Nachman, P.H.; Hogan, S.L.; Jennette, J.C. 2000: ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective Seminars in Nephrology 20(3): 233-243
Hrusková, Z.; Marecková, H.; Ríhová, Z.; Rysavá, R.; Jancová, E.; Merta, M.; Tesar, V. 2008: T cells in the pathogenesis of ANCA-associated vasculitis: current knowledge Folia Biologica 54(3): 81-87
Vazquez, V.; Fayad, A.; González, G.; Smuclir Quevedo, A.; Robaina Sindín, J. 2015: Clinical practice guideline for ANCA-associated vasculitis with renal involvement Medicina 75(Suppl 1): 1-38
Mazzocchi, O.; Risso, J.A.; Viozzi, F.; Apa, N.P.; Peralba, M.C.; Nadal, M.A.; De Rosa, G.E. 2007: Hypertrophic pachymeningitis, glomerulonephritis and P-ANCA associated small vessel vasculitis Medicina 67(2): 151-155
Pralong, G.; Fournier, C.; Dayer, E.; Meier, P. 2009: Goodpasture syndrome associated with p-ANCA microscopic vasculitis: a rare entity to recognize Revue Medicale Suisse 5(207): 1330-1334
Sakaguchi, Y.; Niihata, K.; Yasuda, K.; Shimomura, A.; Uehata, T.; Inoue, K.; Kaneko, T.; Shoji, T.; Tsubakihara, Y.; Okada, N. 2009: Autopsy case of PR3-ANCA-associated vasculitis complicated with rectus muscle hematoma Nihon Jinzo Gakkai Shi 51(5): 550-556
Park, E.S.; Ahn, S.S.; Jung, S.M.; Song, J.J.; Park, Y.-B.; Lee, S.-W. 2018: Renal outcome of kidney-transplantation in Korean recipients with ANCA-associated vasculitis Clinical and Experimental Rheumatology 36 Suppl 111(2): 115-120
Yoo, J.; Ahn, S.S.; Jung, S.M.; Song, J.J.; Park, Y.-B.; Lee, S.-W. 2018: Cancer development in Korean patients with ANCA-associated vasculitis: a single centre study Clinical and Experimental Rheumatology 36 Suppl 111(2): 73-77
Schmitt, W.H.; Paulsen, J.; Rudert, H.; Gross, W.L. 1997: ANCA-associated vasculitis. Wegener disease, microscopic poly-angiitis and Churg-Strauss syndrome Hno 45(6): 477-491
Inaguma, D.; Kurata, K.; Ishihara, S.; Machida, H.; Yaomura, T.; Kumon, S. 1998: A case of MPO-ANCA-related vasculitis that recurred as gastrointestinal bleeding and presented difficulty in treatment Nihon Jinzo Gakkai Shi 40(7): 560-565
Moroni, G.; Binda, V.; Leoni, A.; Raffiotta, F.; Quaglini, S.; Banfi, G.; Messa, P. 2015: Predictors of renal survival in ANCA-associated vasculitis. Validation of a histopatological classification schema and review of the literature Clinical and Experimental Rheumatology 33(2 Suppl. 89): S
Vanková, Z.; Ríhová, Z.; Jancová, E.; Rysavá, R.; Merta, M.; Tesar, V. 2006: Optimizing the therapeutic strategies in ANCA-associated vasculitis--single centre experience with international randomized trials Prague Medical Report 107(2): 199-212
Mull, J.L.; Solus, J.F.; Mutizwa, M.M.; Chiang, H.C.; Rosman, I.S.; Musiek, A. 2015: Atypical propylthiouracil-induced ANCA-positive vasculitis: report of a case with unusual clinical and histopathologic findings Dermatology Online Journal 21(8)